Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 16, 2023

BUY
$1.68 - $2.47 $294 - $432
175 New
175 $0
Q1 2023

May 15, 2023

BUY
$1.87 - $2.6 $19,107 - $26,566
10,218 New
10,218 $19,000
Q3 2022

Nov 03, 2022

SELL
$2.82 - $3.58 $2,557 - $3,247
-907 Reduced 5.48%
15,642 $44,000
Q2 2022

Aug 15, 2022

BUY
$2.59 - $3.92 $8,029 - $12,152
3,100 Added 23.05%
16,549 $47,000
Q1 2022

May 16, 2022

SELL
$3.0 - $4.25 $150 - $212
-50 Reduced 0.37%
13,449 $53,000
Q4 2021

Feb 11, 2022

SELL
$3.85 - $6.71 $16,212 - $28,255
-4,211 Reduced 23.78%
13,499 $53,000
Q3 2021

Nov 10, 2021

SELL
$5.6 - $8.58 $12,527 - $19,193
-2,237 Reduced 11.21%
17,710 $100,000
Q2 2021

Aug 04, 2021

SELL
$7.16 - $9.41 $191,071 - $251,115
-26,686 Reduced 57.23%
19,947 $172,000
Q1 2021

Apr 30, 2021

SELL
$7.52 - $15.55 $28,297 - $58,514
-3,763 Reduced 7.47%
46,633 $441,000
Q4 2020

Jan 29, 2021

BUY
$5.0 - $8.85 $40,515 - $71,711
8,103 Added 19.16%
50,396 $350,000
Q3 2020

Nov 05, 2020

SELL
$4.96 - $7.08 $5,882 - $8,396
-1,186 Reduced 2.73%
42,293 $212,000
Q2 2020

Jul 23, 2020

BUY
$4.84 - $8.02 $3,358 - $5,565
694 Added 1.62%
43,479 $261,000
Q1 2020

May 05, 2020

BUY
$4.52 - $8.55 $37,909 - $71,708
8,387 Added 24.38%
42,785 $243,000
Q4 2019

Jan 30, 2020

SELL
$6.14 - $9.3 $41,979 - $63,584
-6,837 Reduced 16.58%
34,398 $264,000
Q3 2019

Nov 01, 2019

BUY
$9.05 - $16.02 $43,575 - $77,136
4,815 Added 13.22%
41,235 $373,000
Q2 2019

Jul 26, 2019

BUY
$13.58 - $18.61 $53,260 - $72,988
3,922 Added 12.07%
36,420 $582,000
Q1 2019

Apr 24, 2019

BUY
$11.31 - $23.7 $22,834 - $47,850
2,019 Added 6.62%
32,498 $599,000
Q4 2018

Feb 01, 2019

SELL
$6.8 - $12.88 $19,522 - $36,978
-2,871 Reduced 8.61%
30,479 $317,000
Q3 2018

Oct 25, 2018

BUY
$5.65 - $13.75 $84,060 - $204,572
14,878 Added 80.54%
33,350 $371,000
Q2 2018

Jul 20, 2018

BUY
$5.52 - $7.93 $18,409 - $26,446
3,335 Added 22.03%
18,472 $120,000
Q1 2018

Apr 18, 2018

BUY
$5.51 - $10.97 $83,404 - $166,052
15,137 New
15,137 $102,000

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $760M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.